Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy.
Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy. J Cardiovasc Transl Res. 2009 Jun; 2(2):182-90.
View in:
PubMed
subject areas
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-Agonists
Animals
Apolipoprotein A-I
Aspartate Aminotransferases
Biomarkers
Carboxypeptidases A
Cardiomyopathies
Cell Proliferation
Chemokine CCL22
Clenbuterol
C-Reactive Protein
Disease Models, Animal
Endothelial Cells
Fibroblast Growth Factor 2
Gene Expression Regulation
Injections, Subcutaneous
Leukemia Inhibitory Factor
LIM Domain Proteins
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Muscle Proteins
Myocardium
Platelet Endothelial Cell Adhesion Molecule-1
Receptors, Adrenergic, beta-2
RNA, Messenger
Stem Cells
Stroke Volume
Time Factors
Tissue Inhibitor of Metalloproteinase-1
Ventricular Function, Left
authors with profiles
Sean Polster